screenshot of video for Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth

Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth

An ISB-led study examined the electronic health records of more than 18,000 people with SARS-CoV-2 tests during pregnancy, and found that those who contracted COVID-19 while pregnant were more likely to have poor birth outcomes including preterm birth, small for gestational age, low birth weight, and stillbirth. 

Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth
Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth
Lee Hood and Nir Barzilai

Nir Barzilai on Healthspan, Lifespan and the New Science of Longevity

Longevity and aging researcher Dr. Nir Barzilai participated in a fireside chat conversation with ISB Co-founder and Professor Dr. Lee Hood. The two renowned scientists talked about Barzilai’s study of 750 centenarians, how aging research has changed over the years, and what exciting developments are coming. 

Nir Barzilai on Healthspan, Lifespan and the New Science of Longevity
Nir Barzilai on Healthspan, Lifespan and the New Science of Longevity
Microbiome and weight loss

Can You Lose Weight? Ask Your Microbiome

The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome. These new findings open the door to diagnostic tests that can identify people likely to lose weight with healthy lifestyle changes and those who might need more drastic interventions.

Can You Lose Weight? Ask Your Microbiome
Can You Lose Weight? Ask Your Microbiome
screenshot of video for Select Coaching for Cognition in Alzheimer’s (COCOA) Clinical Trial Nearly Complete Coaching for Cognition in Alzheimer’s (COCOA) Clinical Trial Nearly Complete

Coaching for Cognition in Alzheimer’s (COCOA) Clinical Trial Nearly Complete

The multi-year Coaching for Cognition in Alzheimer’s (COCOA) clinical trial is nearly complete. The trial examined diet, exercise and cognitive training as possible non-pharmacological interventions to Alzheimer’s, with some trial members receiving telephonic coaching centered on stress, diet and exercise, as well as brain training focusing on brain speed and attention.

Coaching for Cognition in Alzheimer’s (COCOA) Clinical Trial Nearly Complete
Coaching for Cognition in Alzheimer’s (COCOA) Clinical Trial Nearly Complete
screnshot of video for David Sinclair On Why We Age — And Why We Don't Have To

David Sinclair On Why We Age — And Why We Don't Have To

Dr. David Sinclair, a Harvard Medical School professor and New York Times bestselling author, was the guest of honor for the ISB-Town Hall Science Series on Thursday. He joined genomics pioneer and ISB Co-founder Dr. Lee Hood for a conversation that covered the very latest in aging research.

David Sinclair On Why We Age — And Why We Don't Have To
David Sinclair On Why We Age — And Why We Don't Have To
1 2 3 4 5 6